| scholarly article | Q13442814 |
| P2093 | author name string | Sleight P | |
| Rajagopalan B | |||
| Massie B | |||
| Conway M | |||
| Ledingham J | |||
| Radda G | |||
| Frostick S | |||
| Yonge R | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| heart failure | Q181754 | ||
| congestive heart failure | Q19000661 | ||
| P304 | page(s) | 1009-1019 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. | |
| P478 | volume | 76 |
| Q33888954 | 31P-magnetic resonance spectroscopy assessment of subnormal oxidative metabolism in skeletal muscle of renal failure patients |
| Q54094629 | A neural link to explain the "muscle hypothesis" of exercise intolerance in chronic heart failure. |
| Q36203843 | A perspective on the muscle reflex: implications for congestive heart failure |
| Q41339885 | Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. |
| Q26767412 | Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences |
| Q36832608 | After-effects of exercise on haemodynamics and muscle sympathetic nerve activity in young patients with dilated cardiomyopathy |
| Q54376722 | Alterations of skeletal muscle metabolism in humans studied by phosphorus 31 magnetic resonance spectroscopy in congestive heart failure |
| Q34285835 | Apoptosis and changes in contractile protein pattern in the skeletal muscle in heart failure |
| Q74635681 | Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance |
| Q42628315 | B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. |
| Q41675728 | Beyond ejection fraction. |
| Q39773232 | Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography |
| Q33610760 | Cardiac metabolism during exercise in healthy volunteers measured by 31P magnetic resonance spectroscopy |
| Q36836564 | Cardiac rehabilitation: a comprehensive program for the management of heart failure |
| Q77761589 | Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction |
| Q36814370 | Central haemodynamics and peripheral muscle function during exercise in patients with chronic heart failure |
| Q34774460 | Chronic heart failure and skeletal muscle catabolism: effects of exercise training |
| Q53642030 | Congestive heart failure in elderly patients: controlled study of delapril versus captopril. |
| Q54376727 | Consideration of conduit and resistance vessels in regulation of blood flow. |
| Q49065954 | Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation |
| Q73497366 | Decreased [3H]ouabain binding sites in skeletal muscle of rats with chronic heart failure |
| Q37276462 | Detection of calf muscle alterations in patients with chronic heart failure by P magnetic resonance spectroscopy: Impaired adaptation to continuous exercise. |
| Q39430786 | Determinants of delayed improvement in exercise capacity after percutaneous transvenous mitral commissurotomy |
| Q41869064 | Dissociation between muscle metabolism and oxygen kinetics during recovery from exercise in patients with chronic heart failure |
| Q74081746 | Early development of EMG localized muscle fatigue in hand muscles of patients with chronic heart failure |
| Q41404345 | Effect of dichloroacetate on the exercise performance of patients with heart failure |
| Q84353987 | Effects of chronic heart failure on neuronal nitric oxide synthase-mediated control of microvascular O2 pressure in contracting rat skeletal muscle |
| Q73270987 | Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure |
| Q40935711 | Effects of exercise training on left ventricular filling at rest and during exercise in patients with ischemic cardiomyopathy and severe left ventricular systolic dysfunction |
| Q72360893 | Effects of left ventricular diastolic dysfunction on exercise capacity three to six weeks after acute myocardial infarction in men |
| Q84165738 | Electrical muscle stimulation for chronic heart failure: an alternative tool for exercise training? |
| Q71774413 | Excessive oxygen deficit during low-level exercise in heart failure |
| Q38167670 | Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state. |
| Q77958718 | Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle |
| Q41187847 | Exercise limitation in chronic heart failure: central role of the periphery |
| Q36287326 | Exercise training as therapy for chronic heart failure |
| Q77746908 | Exercise training in heart failure |
| Q79617335 | Exercise training in heart failure |
| Q83309311 | Exercise training in heart failure |
| Q36112969 | Exercise training in heart failure. |
| Q48023234 | Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure |
| Q35371129 | Expression of skeletal muscle sarcoplasmic reticulum calcium-ATPase is reduced in rats with postinfarction heart failure. |
| Q38657978 | Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure |
| Q36046585 | Frequent non-cardiac comorbidities in patients with chronic heart failure |
| Q41845194 | Gas exchange responses to constant work rate exercise in chronic cardiac failure |
| Q81780652 | Heart Failure with Preserved Systolic Function |
| Q54448263 | High- versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats. |
| Q34216442 | Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance |
| Q36979025 | Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training |
| Q77295602 | Importance of intrinsic calf vasodilator capacity in determining distribution of skeletal muscle perfusion during supine bicycle exercise in patients with left ventricular dysfunction |
| Q71517838 | Influence of intrinsic limb vasodilator capacity on exercise tolerance in patients with recent myocardial infarction |
| Q37945453 | Intrinsic skeletal muscle alterations in chronic heart failure patients: a disease-specific myopathy or a result of deconditioning? |
| Q73407962 | Is there a relationship between muscle fatigue resistance and cardiovascular responses to isometric exercise in mild chronic heart failure? |
| Q77212690 | Leg blood flow and increased potassium release during exercise in chronic heart failure: effect of physical training |
| Q36429320 | Magnetic resonance in clinical physiology |
| Q34667465 | Making the case for skeletal myopathy as the major limitation of exercise capacity in heart failure |
| Q35843021 | Metabolic abnormality of calf skeletal muscle is improved by localised muscle training without changes in blood flow in chronic heart failure. |
| Q38052031 | Metabolic and structural impairment of skeletal muscle in heart failure |
| Q40457706 | Metabolic control of the circulation: implications for congestive heart failure. |
| Q50161677 | MicroRNA-432 targeting E2F3 and P55PIK inhibits myogenesis through PI3K/AKT/mTOR signaling pathway |
| Q35886263 | Muscle afferent contributions to the cardiovascular response to isometric exercise |
| Q73206659 | Muscle fibers, ubiquinone and exercise capacity in effort angina |
| Q44283526 | Muscle fibre types, ubiquinone content and exercise capacity in hypertension and effort angina |
| Q36288199 | Muscle reflex control of sympathetic nerve activity in heart failure: the role of exercise conditioning. |
| Q42550276 | Muscle ubiquinone in male effort angina patients |
| Q41192623 | Neuroendocrine changes in chronic cardiac failure |
| Q46119666 | Nuclear magnetic resonance imaging-guided phosphorus-31 spectroscopy of the human heart |
| Q34398182 | Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response |
| Q36256266 | Origin of symptoms in chronic heart failure |
| Q41188641 | Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure |
| Q40702979 | Peripheral factors in the management of congestive heart failure |
| Q34622165 | Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure |
| Q34027206 | Physical training as an adjunct therapy in patients with congestive heart failure: patient selection, training protocols, results, and future directions |
| Q43661073 | Progressive improvement in hemodynamic response to muscle metaboreflex in heart transplant recipients. |
| Q41272674 | Recombinant growth hormone: a new cardiovascular drug therapy |
| Q70060461 | Regional blood flow in congestive heart failure: concept of compensatory mechanisms with short and long time constants |
| Q68498110 | Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure |
| Q37313718 | Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure |
| Q46894691 | Relation of the nine-minute self-powered treadmill test to maximal exercise capacity and skeletal muscle function in patients with congestive heart failure |
| Q47327312 | Relationship between right ventricular ejection fraction and maximum exercise oxygen consumption: a methodological study in chronic heart failure patients |
| Q41488484 | Response to cardiac resynchronization therapy: the muscular metabolic pathway |
| Q72149772 | Response to upright exercise after cardiac transplantation |
| Q38979963 | Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure. |
| Q41192641 | Role of exercise ventilation in the limitation of functional capacity in patients with congestive heart failure |
| Q38596709 | Skeletal Muscle Changes in Chronic Cardiac Disease and Failure. |
| Q91686461 | Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition |
| Q54376743 | Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition. |
| Q34285823 | Skeletal muscle disorders in heart failure |
| Q36833411 | Skeletal muscle metabolism during exercise in patients with chronic heart failure |
| Q74133603 | Skeletal muscle myosin heavy chains in heart failure: correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements |
| Q73919603 | Skeletal muscle oxygenation and oxygen uptake kinetics following constant work rate exercise in chronic congestive heart failure |
| Q34260127 | Skeletal muscle response to exercise training in congestive heart failure |
| Q40915440 | Special populations in cardiovascular rehabilitation. Peripheral arterial disease, non-insulin-dependent diabetes mellitus, and heart failure. |
| Q36836922 | Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. |
| Q33614245 | Symptoms and quality of life in heart failure: the muscle hypothesis. |
| Q46064882 | Temporary fatigue and altered extracellular matrix in skeletal muscle during progression of heart failure in rats |
| Q61650977 | The Ergoreflex in patients with chronic stable heart failure |
| Q73609000 | The effect of physical training on skeletal muscle in patients with chronic heart failure |
| Q34422190 | The effects of resistance exercise on skeletal muscle abnormalities in patients with advanced heart failure |
| Q36840418 | The increased ventilatory response to exercise in chronic heart failure: relation to pulmonary pathology |
| Q39492159 | The management of heart failure: a matter of definition? |
| Q79233385 | The role of exercise therapy in the treatment of patients with systolic heart failure |
| Q74648382 | Use of color kinesis for evaluation of left ventricular filling in patients with dilated cardiomyopathy and mitral regurgitation |
| Q42087276 | Ventilation in chronic heart failure: effects of physical training |
| Q38801305 | V̇o2 kinetics associated with moderate-intensity exercise in heart failure: impact of intrathecal fentanyl inhibition of group III/IV locomotor muscle afferents |
Search more.